Errata
Erratum to: High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study
Erratum to Swiss Med Wkly. 2022;152:w30122 (DOI 10.4414/smw.2022.w30122)
A reference in the discussion section was missing in the original article: at the end of the sentence "A recent published study assessed during the first pandemic
wave the SARS-CoV-2 seroprevalence, COVID-19
symptoms, and comorbidity among OAT patients from one
addiction outpatient unit in Dublin, Ireland" the article "Fenton F, Stokes S, Eagleton M. A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment. Ir J Med Sci. 2021. DOI 10.1007/s11845-021-02660-w" should have been cited. The original article has been corrected and the reference [15] added.
This correction has been made to the online version as of February 1, 2022.
Copyright
Published under the copyright license CC BY-NC-SA: This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
See: smw.ch/permissions
